These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 28042874

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Berberine analogue IMB-Y53 improves glucose-lowering efficacy by averting cellular efflux especially P-glycoprotein efflux.
    Shan YQ, Ren G, Wang YX, Pang J, Zhao ZY, Yao J, You XF, Si SY, Song DQ, Kong WJ, Jiang JD.
    Metabolism; 2013 Mar; 62(3):446-56. PubMed ID: 23079743
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Berberrubine, a Main Metabolite of Berberine, Alleviates Non-Alcoholic Fatty Liver Disease via Modulating Glucose and Lipid Metabolism and Restoring Gut Microbiota.
    Yang S, Cao S, Li C, Zhang J, Liu C, Qiu F, Kang N.
    Front Pharmacol; 2022 Mar; 13():913378. PubMed ID: 35873595
    [Abstract] [Full Text] [Related]

  • 8. Metabolic Activation and Covalent Protein Binding of Berberrubine: Insight into the Underlying Mechanism Related to Its Hepatotoxicity.
    Wang K, Rao J, Zhang T, Gao Q, Zhang J, Guang C, Ding L, Qiu F.
    Drug Des Devel Ther; 2020 Mar; 14():4423-4438. PubMed ID: 33122887
    [Abstract] [Full Text] [Related]

  • 9. Comparative pharmacokinetics and safety assessment of transdermal berberine and dihydroberberine.
    Buchanan B, Meng Q, Poulin MM, Zuccolo J, Azike CG, Gabriele J, Baranowski DC.
    PLoS One; 2018 Mar; 13(3):e0194979. PubMed ID: 29579096
    [Abstract] [Full Text] [Related]

  • 10. Tissue distribution of berberine and its metabolites after oral administration in rats.
    Tan XS, Ma JY, Feng R, Ma C, Chen WJ, Sun YP, Fu J, Huang M, He CY, Shou JW, He WY, Wang Y, Jiang JD.
    PLoS One; 2013 Mar; 8(10):e77969. PubMed ID: 24205048
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Combined analytical approaches to define biodistribution and biological activity of semi-synthetic berberrubine, the active metabolite of natural berberine.
    Porru E, Franco P, Calabria D, Spinozzi S, Roberti M, Caliceti C, Roda A.
    Anal Bioanal Chem; 2018 Jun; 410(15):3533-3545. PubMed ID: 29411090
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. 8,8-Dimethyldihydroberberine with improved bioavailability and oral efficacy on obese and diabetic mouse models.
    Cheng Z, Chen AF, Wu F, Sheng L, Zhang HK, Gu M, Li YY, Zhang LN, Hu LH, Li JY, Li J.
    Bioorg Med Chem; 2010 Aug 15; 18(16):5915-24. PubMed ID: 20663675
    [Abstract] [Full Text] [Related]

  • 19. Berberine metabolites could induce low density lipoprotein receptor up-regulation to exert lipid-lowering effects in human hepatoma cells.
    Zhou Y, Cao S, Wang Y, Xu P, Yan J, Bin W, Qiu F, Kang N.
    Fitoterapia; 2014 Jan 15; 92():230-7. PubMed ID: 24321576
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.